Published in Mol Biotechnol on November 01, 2010
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells (2013) 1.42
Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet (2012) 1.38
BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Reports (2013) 1.09
An improved technique for chromosomal analysis of human ES and iPS cells. Stem Cell Rev (2011) 1.04
Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface (2010) 1.02
A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. Cell Death Differ (2013) 0.99
Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source. Stem Cells Transl Med (2014) 0.92
Aneuploidy in pluripotent stem cells and implications for cancerous transformation. Protein Cell (2014) 0.85
High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivation. Cell Biosci (2014) 0.85
Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Stem Cell Rev (2017) 0.81
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells. Stem Cell Reports (2017) 0.77
High-Resolution Genomic Profiling of Chromosomal Abnormalities in Human Stem Cells Using the 135 K StemArray. Stem Cells Int (2012) 0.75
Comprehensive characterization of genomic instability in pluripotent stem cells and their derived neuroprogenitor cell lines. Appl Transl Genom (2012) 0.75
Derivation and long-term culture of transgene-free human induced pluripotent stem cells on synthetic substrates. Stem Cells Transl Med (2014) 0.75
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells. Stem Cell Reports (2017) 0.75
Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process. Int J Mol Sci (2017) 0.75
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol (2011) 3.45
Rapid detection of the ACMG/ACOG-recommended 23 CFTR disease-causing mutations using ion torrent semiconductor sequencing. J Biomol Tech (2012) 1.40
Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas (2006) 1.34
Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev Biol (2002) 1.10
Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice. Neuromuscul Disord (2003) 1.05
Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum. J Mol Diagn (2005) 1.04
Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily a, member 3 genes. J Pediatr (2009) 0.95
Improved detection of cystic fibrosis mutations in infertility patients with DNA sequence analysis. Hum Reprod (2004) 0.82
Characterization of a recurrent novel large duplication in the cystic fibrosis transmembrane conductance regulator gene. J Mol Diagn (2007) 0.80
Platelet hexosaminidase a enzyme assay effectively detects carriers missed by targeted DNA mutation analysis. JIMD Rep (2012) 0.79
Array-comparative genomic hybridization characterization of human pluripotent stem cells. Methods Mol Biol (2012) 0.76
High-Resolution Genomic Profiling of Chromosomal Abnormalities in Human Stem Cells Using the 135 K StemArray. Stem Cells Int (2012) 0.75
The role of the F508C mutation in congenital bilateral absence of the vas deferens. Genet Med (2008) 0.75